Literature DB >> 10712584

New functions of a long-known molecule. Emerging roles of NAD in cellular signaling.

M Ziegler1.   

Abstract

Over the past decades, the pyridine nucleotides have been established as important molecules in signaling pathways, besides their well known function in energy transduction. Similarly to another molecule carrying such dual functions, ATP, NAD(P)+ may serve as substrate for covalent protein modification or as precursor of biologically active compounds. Protein modification is catalyzed by ADP-ribosyl transferases that attach the ADP-ribose moiety of NAD+ to specific amino-acid residues of the acceptor proteins. For a number of ADP ribosylation reactions the specific transferases and their target proteins have been identified. As a result of the modification, the biological activity of the acceptor proteins may be severely changed. The cell nucleus contains enzymes catalyzing the transfer of ADP-ribose polymers (polyADP-ribose) onto the acceptor proteins. The best known enzyme of this type is poly(ADP-ribose) polymerase 1 (PARP1), which has been implicated in the regulation of several important processes including DNA repair, transcription, apoptosis, neoplastic transformation and others. The second group of reactions leads to the synthesis of an unusual cyclic nucleotide, cyclic ADP-ribose (cADPR). Moreover, the enzymes catalyzing this reaction may also replace the nicotinamide of NADP+ by nicotinic acid resulting in the synthesis of nicotinic acid adenine dinucleotide phosphate (NAADP+). Both cADPR and NAADP+ have been reported to be potent intracellular calcium-mobilizing agents. In concert with inositol 1,4,5-trisphosphate, they participate in cytosolic calcium regulation by releasing calcium from intracellular stores.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712584     DOI: 10.1046/j.1432-1327.2000.01187.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  74 in total

Review 1.  Nicotinamide: a jack of all trades (but master of none?).

Authors:  Csaba Szabó
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

2.  Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria.

Authors:  A Herrero-Yraola; S M Bakhit; P Franke; C Weise; M Schweiger; D Jorcke; M Ziegler
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

4.  Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes.

Authors:  Claudia A Benavente; Elaine L Jacobson
Journal:  Free Radic Biol Med       Date:  2007-10-17       Impact factor: 7.376

5.  Genetically encoded fluorescent indicator for imaging NAD(+)/NADH ratio changes in different cellular compartments.

Authors:  Dmitry S Bilan; Mikhail E Matlashov; Andrey Yu Gorokhovatsky; Carsten Schultz; Grigori Enikolopov; Vsevolod V Belousov
Journal:  Biochim Biophys Acta       Date:  2013-11-25

6.  The action of extracellular NAD+ on gluconeogenesis in the perfused rat liver.

Authors:  Adriana G Martins; Jorgete Constantin; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

7.  Comparative genomics of NAD biosynthesis in cyanobacteria.

Authors:  Svetlana Y Gerdes; Oleg V Kurnasov; Konstantin Shatalin; Boris Polanuyer; Roman Sloutsky; Veronika Vonstein; Ross Overbeek; Andrei L Osterman
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

8.  Transformation and action of extracellular NAD+ in perfused rat and mouse livers.

Authors:  Ana Carla Broetto-Biazon; Fabrício Bracht; Livia Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

9.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.

Authors:  Sang-Young Kim; Bruce M Cohen; Xi Chen; Scott E Lukas; Ann K Shinn; A Cagri Yuksel; Tao Li; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2016-09-24       Impact factor: 9.306

Review 10.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.